Walvax Biotechnology (300142.SZ): The net income for the first half of the year was 0.171 billion yuan, a year-on-year decrease of 62.53%.

Gelonghui Finance · Aug 27 21:24

gelonhui August 27th, walvax biotechnology (300142.SZ) released the interim report for the first half of 2024, with a total operating income of 1.433 billion yuan during the reporting period, a year-on-year decrease of 33.88%; net income attributable to shareholders of the listed company was 0.171 billion yuan, a year-on-year decrease of 62.53%; net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 0.146 billion yuan, a year-on-year decrease of 65.39%; basic earnings per share was 0.1066 yuan.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more

沃森生物(300142.SZ)：上半年净利润1.71亿元，同比下降62.53%

Walvax Biotechnology (300142.SZ): The net income for the first half of the year was 0.171 billion yuan, a year-on-year decrease of 62.53%.

Risk Disclaimer

Statement